Vitamina K (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vitamina K" in Galician language version.

refsWebsite

Global rank Galician rank

76nih.gov

4^th place

6^th place

59doi.org

2^nd place

7^th place

12archive.org

6^th place

8^th place

7web.archive.org

1^st place

3ajcn.org

low place

2,691^st place

2elsevier.com

610^th place

214^th place

2nutritiondata.com

low place

2asm.org

3,555^th place

450^th place

1oregonstate.edu

2,041^st place

1,692^nd place

1hematologylibrary.org

low place

2,448^th place

1schattauer.de

low place

1nutrition.org

7,878^th place

1,947^th place

1chestjournal.org

low place

1annals.org

low place

6,362^nd place

1colostate.edu

3,616^th place

2,226^th place

1springer.com

274^th place

251^st place

1westonaprice.org

low place

1oup.com

485^th place

312^th place

1worldcat.org

5^th place

11^th place

1womentowomen.com

low place

1jst.go.jp

1,903^rd place

1,398^th place

1wiley.com

222^nd place

134^th place

1nutraingredients.com

low place

1nobelprize.org

301^st place

128^th place

1jbc.org

4,455^th place

611^th place

ajcn.org

Nimptsch K, Rohrmann S, Kaaks R, Linseisen J (2010). "Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg)". Am. J. Clin. Nutr. 91 (5): 1348–58. PMID 20335553. doi:10.3945/ajcn.2009.28691.
Feskanich, Diane; Weber, P; Willett, W; Rockett, H; Booth, S; Colditz, G (1999). "Vitamin K intake and hip fractures in women: a prospective study". American Journal of Clinical Nutrition 69 (1): 74–9. PMID 9925126.
Nimptsch K, Rohrmann S, Linseisen J (2008). "Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition. (EPIC-Heidelberg)". Am. J. Clin. Nutr. 87 (4): 985–92. PMID 18400723.

annals.org

Crowther MA, Douketis JD, Schnurr T; et al. (2002). "Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial" (PDF). Ann. Intern. Med. 137 (4): 251–4. PMID 12186515.

archive.org

Will, BH; Usui Y, Suttie JW (1992). "Comparative Metabolism and Requirement of Vitamin K in Chicks and Rats". Journal of Nutrition 122 (12): 2354–2360. PMID 1453219.
Weber, P (2001). "Vitamin K and bone health". Nutrition 17 (10): 880–887. PMID 11684396. doi:10.1016/S0899-9007(01)00709-2.
Price PA (1988). "Role of vitamin-K-dependent proteins in bone metabolism". Annu. Rev. Nutr. 8: 565–83. PMID 3060178. doi:10.1146/annurev.nu.08.070188.003025.
Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD, Galipeau J (2008). "Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells". J. Biol. Chem. 283 (26): 17991–18001. PMID 18450759. doi:10.1074/jbc.M708029200.
Ronden, JE; Groenen-van Dooren MMCL, Hornstra G, Vermeer C (1997). "Modulation of arterial thrombosis tendency in rats by vitamin K and its side chains". Atherosclerosis 132 (1): 61–67. PMID 9247360. doi:10.1016/S0021-9150(97)00087-7.
Ikeda; Iki, M; Morita, A; Kajita, E; Kagamimori, S; Kagawa, Y; Yoneshima, H (2006). "Intake of fermented soybeans, natto, is associated with reduced bone loss in postmenopausal women: Japanese Population-Based Osteoporosis (JPOS) Study". The Journal of nutrition 136 (5): 1323–8. PMID 16614424.
Suttie JW (1985). "Vitamin K-dependent carboxylase". Annu. Rev. Biochem. 54: 459–77. PMID 3896125. doi:10.1146/annurev.bi.54.070185.002331.
Terlau H, Olivera BM (2004). "Conus venoms: a rich source of novel ion channel-targeted peptides". Physiol. Rev. 84 (1): 41–68. PMID 14715910. doi:10.1152/physrev.00020.2003.
Buczek O, Bulaj G, Olivera BM (2005). "Conotoxins and the posttranslational modification of secreted gene products". Cell. Mol. Life Sci. 62 (24): 3067–79. PMID 16314929. doi:10.1007/s00018-005-5283-0.
Kanai, T (1997). "Serum vitamin K level and bone mineral density in post-menopausal women". International Journal of Gynecology & Obstetrics 56: 25. doi:10.1016/S0020-7292(96)02790-7.
Booth SL, Tucker K, Chen H; et al. (2000). "Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women". Am J Clin Nutr 71 (5): 1201–1208. PMID 10799384.
Magnusson S, Sottrup-Jensen L, Petersen TE, Morris HR, Dell A (1974). "Primary structure of the vitamin K-dependent part of prothrombin". FEBS Lett. 44 (2): 189–93. PMID 4472513. doi:10.1016/0014-5793(74)80723-4.

asm.org

mmbr.asm.org

Bentley R, Meganathan R (1982). "Biosynthesis of vitamin K (menaquinone) in bacteria". Microbiol. Rev. 46 (3): 241–80. PMC 281544. PMID 6127606.
Haddock BA, Jones CW (1977). "Bacterial respiration". Bacteriol Rev 41 (1): 47–99. PMC 413996. PMID 140652.

chestjournal.org

Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E (2004). "The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy". Chest 126 (3 Suppl): 204S–233S. PMID 15383473. doi:10.1378/chest.126.3_suppl.204S. Arquivado dende o orixinal o 30 de decembro de 2008. Consultado o 01 de novembro de 2011. (summary Arquivado 11 de outubro de 2008 en Wayback Machine.)

colostate.edu

vivo.colostate.edu

"NutritionData.com". Arquivado dende o orixinal o 17 de novembro de 2011. Consultado o 01 de novembro de 2011.

doi.org

dx.doi.org

Dam, H. (1935). "The Antihæmorrhagic Vitamin of the Chick.: Occurrence And Chemical Nature". Nature 135 (3417): 652–653. doi:10.1038/135652b0.
Sell, DR; Monnier VM (1990). "End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen". Journal of Clinical Investigation 85 (2): 380–384. PMC 296435. PMID 2298912. doi:10.1172/JCI114449.
Ronden, JE; Drittij-Reijnders M-J, Vermeer C, Thijssen HHW. (1998). "Intestinal flora is not an intermediate in the phylloquinone-menaquinone-4 conversion in the rat". Biochimica et Biophysica Acta (BBA) - General Subjects 1379 (1): 69–75. PMID 9468334. doi:10.1016/S0304-4165(97)00089-5.
Thijssen, HHW; Drittij-Reijnders MJ (1994). "Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone-4". British Journal of Nutrition 72 (3): 415–425. PMID 7947656. doi:10.1079/BJN19940043.
Ronden, JE; Drittij-Reijnders M-J, Vermeer C, Thijssen HHW (1998). "Intestinal flora is not an intermediate in the phylloquinone-menaquinone-4 conversion in the rat". Biochimica et Biophysica Acta (BBA) - General Subjects 1379 (1): 69–75. PMID 9468334. doi:10.1016/S0304-4165(97)00089-5.
Vermeer, C; Braam L (2001). "Role of K vitamins in the regulation of tissue calcification". Journal of bone and mineral metabolism 19 (4): 201–206. PMID 11448011. doi:10.1007/s007740170021.
Suttie, JW (1995). "The importance of menaquinones in human nutrition". Annual Review of Nutrition 15: 399–417. PMID 8527227. doi:10.1146/annurev.nu.15.070195.002151.
Weber, P (2001). "Vitamin K and bone health". Nutrition 17 (10): 880–887. PMID 11684396. doi:10.1016/S0899-9007(01)00709-2.
Price PA (1988). "Role of vitamin-K-dependent proteins in bone metabolism". Annu. Rev. Nutr. 8: 565–83. PMID 3060178. doi:10.1146/annurev.nu.08.070188.003025.
Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD, Galipeau J (2008). "Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells". J. Biol. Chem. 283 (26): 17991–18001. PMID 18450759. doi:10.1074/jbc.M708029200.
Hafizi S, Dahlbäck B (2006). "Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily". FEBS J. 273 (23): 5231–44. PMID 17064312. doi:10.1111/j.1742-4658.2006.05529.x.
Kulman JD, Harris JE, Xie L, Davie EW (2007). "Proline-rich Gla protein 2 is a cell-surface vitamin K-dependent protein that binds to the transcriptional coactivator Yes-associated protein". Proc. Natl. Acad. Sci. U.S.A. 104 (21): 8767–72. PMC 1885577. PMID 17502622. doi:10.1073/pnas.0703195104.
Ferland G, Sadowski JA, O'Brien ME (1993). "Dietary induced subclinical vitamin K deficiency in normal human subjects". J. Clin. Invest. 91 (4): 1761–8. PMC 288156. PMID 8473516. doi:10.1172/JCI116386.
Groenen-van Dooren MM, Ronden JE, Soute BA, Vermeer C (1995). "Bioavailability of phylloquinone and menaquinones after oral and colorectal administration in vitamin K-deficient rats". Biochem. Pharmacol. 50 (6): 797–801. PMID 7575640. doi:10.1016/0006-2952(95)00202-B.
Beulens JW, Bots ML, Atsma F; et al. (2009). "High dietary menaquinone intake is associated with reduced coronary calcification". Atherosclerosis 203 (2): 489–93. PMID 18722618. doi:10.1016/j.atherosclerosis.2008.07.010.
Nimptsch K, Rohrmann S, Kaaks R, Linseisen J (2010). "Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg)". Am. J. Clin. Nutr. 91 (5): 1348–58. PMID 20335553. doi:10.3945/ajcn.2009.28691.
Ushiroyama, T; Ikeda A, Ueki M (2002). "Effect of continuous combined therapy with vitamin K2 and vitamin D3 on bone mineral density and coagulofibrinolysis function in postmenopausal women". Maturitas 41 (3): 211–221. PMID 11886767. doi:10.1016/S0378-5122(01)00275-4.
Asakura, H; Myou S, Ontachi Y, Mizutani T, Kato M, Saito M, Morishita E, Yamazaki M, Nakao S (2001). "Vitamin K administration to elderly patients with osteoporosis induces no hemostatic activation, even in those with suspected vitamin K deficiency". Osteoporosis International 12 (12): 996–1000. PMID 11846334. doi:10.1007/s001980170007.
Ronden, JE; Groenen-van Dooren MMCL, Hornstra G, Vermeer C (1997). "Modulation of arterial thrombosis tendency in rats by vitamin K and its side chains". Atherosclerosis 132 (1): 61–67. PMID 9247360. doi:10.1016/S0021-9150(97)00087-7.
Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E (2004). "The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy". Chest 126 (3 Suppl): 204S–233S. PMID 15383473. doi:10.1378/chest.126.3_suppl.204S. Arquivado dende o orixinal o 30 de decembro de 2008. Consultado o 01 de novembro de 2011. (summary Arquivado 11 de outubro de 2008 en Wayback Machine.)
Elder SJ, Haytowitz DB, Howe J, Peterson JW, Booth SL (2006). "Vitamin k contents of meat, dairy, and fast food in the U.S. Diet". J. Agric. Food Chem. 54 (2): 463–7. PMID 16417305. doi:10.1021/jf052400h.
Tsukamoto Y, Ichise H, Kakuda H, Yamaguchi M (2000). "Intake of fermented soybean (natto) increases circulating vitamin K₂ (menaquinone-7) and gamma-carboxylated osteocalcin concentration in normal individuals". J. Bone Miner. Metab. 18 (4): 216–22. PMID 10874601. doi:10.1007/s007740070023.
Katsuyama; Ideguchi, S; Fukunaga, M; Saijoh, K; Sunami, S (2002). "Usual dietary intake of fermented soybeans (Natto) is associated with bone mineral density in premenopausal women". Journal of nutritional science and vitaminology 48 (3): 207–15. PMID 12350079. doi:10.3177/jnsv.48.207.
Sano; Fujita, H; Morita, I; Uematsu, H; Murota, S (1999). "Vitamin K2 (menatetrenone) induces iNOS in bovine vascular smooth muscle cells: no relationship between nitric oxide production and gamma-carboxylation". Journal of nutritional science and vitaminology 45 (6): 711–23. PMID 10737225. doi:10.3177/jnsv.45.711.
Geleijnse, Johanna M.; Vermeer, Cees; Grobbee, Diederick E.; Schurgers, Leon J.; Knapen, Marjo H. J.; van der Meer, Irene M.; Hofman, Albert; Witteman, Jacqueline C. M. (2004-11-01). "Dietary Intake of Menaquinone Is Associated with a Reduced Risk of Coronary Heart Disease: The Rotterdam Study". The Journal of Nutrition (en inglés) 134 (11): 3100–3105. ISSN 0022-3166. doi:10.1093/jn/134.11.3100.
Oldenburg J, Bevans CG, Müller CR, Watzka M (2006). "Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle". Antioxid. Redox Signal. 8 (3–4): 347–53. PMID 16677080. doi:10.1089/ars.2006.8.347.
Suttie JW (1985). "Vitamin K-dependent carboxylase". Annu. Rev. Biochem. 54: 459–77. PMID 3896125. doi:10.1146/annurev.bi.54.070185.002331.
Stafford DW (2005). "The vitamin K cycle". J. Thromb. Haemost. 3 (8): 1873–8. PMID 16102054. doi:10.1111/j.1538-7836.2005.01419.x.
Whitlon DS, Sadowski JA, Suttie JW (1978). "Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition". Biochemistry 17 (8): 1371–7. PMID 646989. doi:10.1021/bi00601a003.
Terlau H, Olivera BM (2004). "Conus venoms: a rich source of novel ion channel-targeted peptides". Physiol. Rev. 84 (1): 41–68. PMID 14715910. doi:10.1152/physrev.00020.2003.
Buczek O, Bulaj G, Olivera BM (2005). "Conotoxins and the posttranslational modification of secreted gene products". Cell. Mol. Life Sci. 62 (24): 3067–79. PMID 16314929. doi:10.1007/s00018-005-5283-0.
Gerald JA, Katie JW, Asiri R W; et al. (2009). "Vitamin K promotes mineralization, osteoblast‐to‐osteocyte transition, and an anticatabolic phenotype by γ‐carboxylation‐dependent and independent mechanisms". Am J Physiol Cell Physiol 297 (6): C1358–C1367. PMID 19675304. doi:10.1152/ajpcell.00216.2009.
Lian J, Stewart C, Puchacz E, Mackowiak S, Shalhoub V, Collart D, Zambetti G & Stein G (1989). "Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression". Proc Natl Acad Sci 86 (4): 1143–1147. PMC 286642. PMID 2784002. doi:10.1073/pnas.86.4.1143.
Kanai, T (1997). "Serum vitamin K level and bone mineral density in post-menopausal women". International Journal of Gynecology & Obstetrics 56: 25. doi:10.1016/S0020-7292(96)02790-7.
Cheung, AM; Weber, P; Willett, WC; Rockett, H; Booth, SL; Colditz, GA; Hu, H; Vieth, R; Thompson, L (2008). Torgerson, David, ed. "Vitamin K Supplementation in Postmenopausal Women with Osteopenia (ECKO Trial): A Randomized Controlled Trial". PLoS Med. 5 (10): e196. PMC 2566998. PMID 18922041. doi:10.1371/journal.pmed.0050196.
Tsukamoto Y (2004). "Studies on action of menaquinone-7 in regulation of bone metabolism and its preventive role of osteoporosis". BioFactors 22 (1-4): 5–19. PMID 15630245. doi:10.1002/biof.5520220102.
Sato, Y; Kanoko T, Satoh K, Iwamoto J (2005). "Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease". Bone 36 (1): 61–8. PMID 15664003. doi:10.1016/j.bone.2004.09.018.
Iwamoto, I; Kosha S, Noguchi S-i (1999). "A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy". Maturitas 31 (2): 161–164. PMID 10227010. doi:10.1016/S0378-5122(98)00114-5.
Inoue, T; Sugiyama T, Matsubara T, Kawai S, Furukawa S (2001). "Inverse correlation between the changes of lumbar bone mineral density and serum undercarboxylated osteocalcin after vitamin K2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol". Endocrine Journal 48 (1): 11–18. PMID 11403096. doi:10.1507/endocrj.48.11.
Sasaki, N, Kusano E, Takahashi H, Ando Y, Yano K, Tsuda E, Asano Y; Kusano E, Takahashi H, Ando Y, Yano K, Tsuda E, Asano Y (2005). "Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG)". Journal of bone and mineral metabolism 23 (1): 41–47. PMID 15616893. doi:10.1007/s00774-004-0539-6.
Yonemura, K; Kimura M, Miyaji T, Hishida A (2000). "Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis". Calcified Tissue International 66 (2): 123–128. PMID 10652960. doi:10.1007/PL00005832.
Iketani, T; Kiriike N, B. Stein M (2003). "Effect of menatetrenone (vitamin K2) treatment on bone loss in patients with anorexia nervosa". Psychiatry Research 117 (3): 259–269. PMID 12686368. doi:10.1016/S0165-1781(03)00024-6.
Shiomi, S; Nishiguchi S, Kubo S (2002). "Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver". The American Journal of Gastroenterology 97 (4): 978–981. PMID 12003435. doi:10.1111/j.1572-0241.2002.05618.x.
Cockayne, S; Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ (2006). "Vitamin K and the Prevention of Fractures: Systematic Review and Meta-analysis of Randomized Controlled Trials". Archives of Internal Medicine 166 (12): 1256–1261. PMID 16801507. doi:10.1001/archinte.166.12.1256.
Iwamoto, J; Takeda T, Ichimura S (2000). "Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis". Journal of Orthopaedic Science 5 (6): 546–551. PMID 11180916. doi:10.1007/s007760070003.
Purwosunu, Y; Muharram, Rachman IA, Reksoprodjo S, Sekizawa A (2006). "Vitamin K2 treatment for postmenopausal osteoporosis in Indonesia". The journal of obstetrics and gynaecology research 32 (2): 230–234. PMID 16594930. doi:10.1111/j.1447-0756.2006.00386.x.
Shiraki, M; Shiraki Y, Aoki C, Miura M (2000). "Vitamin K2 (Menatetrenone) Effectively Prevents Fractures and Sustains Lumbar Bone Mineral Density in Osteoporosis". Journal of Bone and Mineral Research 15 (3): 515–522. PMID 10750566. doi:10.1359/jbmr.2000.15.3.515.
Sato, Y; Honda Y, Kuno H, Oizumi K (1998). "Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients". Bone 23 (3): 291–296. PMID 9737352. doi:10.1016/S8756-3282(98)00108-2.
Sato, Y; Kanoko T, Satoh K, Iwamoto J (2005). "Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease". Bone 36 (1): 61–68. PMID 15664003. doi:10.1016/j.bone.2004.09.018.
Sato, Y; Honda Y, Kaji M (2002). "Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency". Bone 31 (1): 114–118. PMID 12110423. doi:10.1016/S8756-3282(02)00783-4.
Nishiguchi, S; Shimoi S, Kurooka H (2001). "Randomized pilot trial of vitamin K2 for bone loss in patients with primary biliary cirrhosis". Journal of Hepatology 35 (4): 543–545. PMID 11682046. doi:10.1016/S0168-8278(01)00133-7.
Somekawa, Y; Chigughi M, Harada M, Ishibashi T (1999). "Use of vitamin K2 (menatetrenone) and 1,25-dihydroxyvitamin D3 in the prevention of bone loss induced by leuprolide". The Journal of clinical endocrinology and metabolism 84 (8): 2700–2704. PMID 10443663. doi:10.1210/jc.84.8.2700.
Allison (2001). "The possible role of vitamin K deficiency in the pathogenesis of Alzheimer's disease and in augmenting brain damage associated with cardiovascular disease". Medical hypotheses 57 (2): 151–5. PMID 11461163. doi:10.1054/mehy.2001.1307.
Saxena SP, Israels ED, Israels LG (2001). "Novel vitamin K-dependent pathways regulating cell survival". Apoptosis 6 (1–2): 57–68. PMID 11321042. doi:10.1023/A:1009624111275.
Spronk, HMH; Soute BAM, Schurgers LJ, Thijssen HHW, De Mey JGR, Vermeer C (2003). "Tissue-Specific Utilization of Menaquinone-4 Results in the Prevention of Arterial Calcification in Warfarin-Treated Rats". Journal of vascular research 40 (6): 531–537. PMID 14654717. doi:10.1159/000075344.
MacCorquodale, D. W.; Binkley, S. B.; Thayer, S. A.; Doisy, E. A. (1939). "On the constitution of Vitamin K1". Journal of the American Chemical Society 61 (7): 1928–1929. doi:10.1021/ja01876a510.
Fieser, L. F. (1939). "Synthesis of Vitamin K1". Journal of the American Chemical Society 61 (12): 3467–3475. doi:10.1021/ja01267a072.
Stenflo J, Fernlund P, Egan W, Roepstorff P (1974). "Vitamin K Dependent Modifications of Glutamic Acid Residues in Prothrombin". Proc. Natl. Acad. Sci. U.S.A. 71 (7): 2730–3. PMC 388542. PMID 4528109. doi:10.1073/pnas.71.7.2730.
Magnusson S, Sottrup-Jensen L, Petersen TE, Morris HR, Dell A (1974). "Primary structure of the vitamin K-dependent part of prothrombin". FEBS Lett. 44 (2): 189–93. PMID 4472513. doi:10.1016/0014-5793(74)80723-4.

elsevier.com

linkinghub.elsevier.com

Groenen-van Dooren MM, Ronden JE, Soute BA, Vermeer C (1995). "Bioavailability of phylloquinone and menaquinones after oral and colorectal administration in vitamin K-deficient rats". Biochem. Pharmacol. 50 (6): 797–801. PMID 7575640. doi:10.1016/0006-2952(95)00202-B.
Beulens JW, Bots ML, Atsma F; et al. (2009). "High dietary menaquinone intake is associated with reduced coronary calcification". Atherosclerosis 203 (2): 489–93. PMID 18722618. doi:10.1016/j.atherosclerosis.2008.07.010.

hematologylibrary.org

bloodjournal.hematologylibrary.org

Furie B, Bouchard BA, Furie BC (15 March 1999). "Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid". Blood 93 (6): 1798–808. PMID 10068650. Arquivado dende o orixinal o 12 de febreiro de 2009. Consultado o 01 de novembro de 2011.

jbc.org

Nelsestuen GL, Zytkovicz TH, Howard JB (1974). "The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin". J. Biol. Chem. 249 (19): 6347–50. PMID 4214105. Arquivado dende o orixinal o 19 de setembro de 2019. Consultado o 01 de novembro de 2011.

jst.go.jp

jstage.jst.go.jp

Yamaguchi M (2006). "Regulatory mechanism of food factors in bone metabolism and prevention of osteoporosis". Yakugaku Zasshi 126 (11): 1117–37. PMID 17077614.

nih.gov

ncbi.nlm.nih.gov

Sell, DR; Monnier VM (1990). "End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen". Journal of Clinical Investigation 85 (2): 380–384. PMC 296435. PMID 2298912. doi:10.1172/JCI114449.
Davidson, RT; Foley AL, Engelke JA, Suttie JW (1998). "Conversion of Dietary Phylloquinone to Tissue Menaquinone-4 in Rats is Not Dependent on Gut Bacteria1". Journal of Nutrition 128 (2): 220–223. PMID 9446847.
Ronden, JE; Drittij-Reijnders M-J, Vermeer C, Thijssen HHW. (1998). "Intestinal flora is not an intermediate in the phylloquinone-menaquinone-4 conversion in the rat". Biochimica et Biophysica Acta (BBA) - General Subjects 1379 (1): 69–75. PMID 9468334. doi:10.1016/S0304-4165(97)00089-5.
Thijssen, HHW; Drittij-Reijnders MJ (1994). "Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone-4". British Journal of Nutrition 72 (3): 415–425. PMID 7947656. doi:10.1079/BJN19940043.
Will, BH; Usui Y, Suttie JW (1992). "Comparative Metabolism and Requirement of Vitamin K in Chicks and Rats". Journal of Nutrition 122 (12): 2354–2360. PMID 1453219.
Davidson, RT; Foley AL, Engelke JA, Suttie JW (1998). "Conversion of Dietary Phylloquinone to Tissue Menaquinone-4 in Rats is Not Dependent on Gut Bacteria". Journal of Nutrition 128 (2): 220–223. PMID 9446847.
Ronden, JE; Drittij-Reijnders M-J, Vermeer C, Thijssen HHW (1998). "Intestinal flora is not an intermediate in the phylloquinone-menaquinone-4 conversion in the rat". Biochimica et Biophysica Acta (BBA) - General Subjects 1379 (1): 69–75. PMID 9468334. doi:10.1016/S0304-4165(97)00089-5.
Vermeer, C; Braam L (2001). "Role of K vitamins in the regulation of tissue calcification". Journal of bone and mineral metabolism 19 (4): 201–206. PMID 11448011. doi:10.1007/s007740170021.
Suttie, JW (1995). "The importance of menaquinones in human nutrition". Annual Review of Nutrition 15: 399–417. PMID 8527227. doi:10.1146/annurev.nu.15.070195.002151.
Weber, P (2001). "Vitamin K and bone health". Nutrition 17 (10): 880–887. PMID 11684396. doi:10.1016/S0899-9007(01)00709-2.
Furie B, Bouchard BA, Furie BC (15 March 1999). "Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid". Blood 93 (6): 1798–808. PMID 10068650. Arquivado dende o orixinal o 12 de febreiro de 2009. Consultado o 01 de novembro de 2011.
Mann KG (1999). "Biochemistry and physiology of blood coagulation". Thromb. Haemost. 82 (2): 165–74. PMID 10605701. Arquivado dende o orixinal o 02 de xaneiro de 2009. Consultado o 01 de novembro de 2011.
Price PA (1988). "Role of vitamin-K-dependent proteins in bone metabolism". Annu. Rev. Nutr. 8: 565–83. PMID 3060178. doi:10.1146/annurev.nu.08.070188.003025.
Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD, Galipeau J (2008). "Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells". J. Biol. Chem. 283 (26): 17991–18001. PMID 18450759. doi:10.1074/jbc.M708029200.
Hafizi S, Dahlbäck B (2006). "Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily". FEBS J. 273 (23): 5231–44. PMID 17064312. doi:10.1111/j.1742-4658.2006.05529.x.
Kulman JD, Harris JE, Xie L, Davie EW (2007). "Proline-rich Gla protein 2 is a cell-surface vitamin K-dependent protein that binds to the transcriptional coactivator Yes-associated protein". Proc. Natl. Acad. Sci. U.S.A. 104 (21): 8767–72. PMC 1885577. PMID 17502622. doi:10.1073/pnas.0703195104.
Conly, J; Stein K (1994). "Reduction of vitamin K2 concentrations in human liver associated with the use of broad spectrum antimicrobials". Clinical and investigative medicine. Médecine clinique et experimentale 17 (6): 531–539. PMID 7895417.
Ferland G, Sadowski JA, O'Brien ME (1993). "Dietary induced subclinical vitamin K deficiency in normal human subjects". J. Clin. Invest. 91 (4): 1761–8. PMC 288156. PMID 8473516. doi:10.1172/JCI116386.
Hodges SJ, Pilkington MJ, Shearer MJ, Bitensky L, Chayen J (1990). "Age-related changes in the circulating levels of congeners of vitamin K2, menaquinone-7 and menaquinone-8". Clin. Sci. 78 (1): 63–6. PMID 2153497.
Groenen-van Dooren MM, Ronden JE, Soute BA, Vermeer C (1995). "Bioavailability of phylloquinone and menaquinones after oral and colorectal administration in vitamin K-deficient rats". Biochem. Pharmacol. 50 (6): 797–801. PMID 7575640. doi:10.1016/0006-2952(95)00202-B.
Komai M, Shirakawa H (2007). "Vitamin K metabolism. Menaquinone-4 (MK-4) formation from ingested VK analogues and its potent relation to bone function". Clin Calcium (en Japanese) 17 (11): 1663–72. PMID 17982185.
Geleijnse JM, Vermeer C, Grobbee DE; et al. (2004). "Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study". J. Nutr. 134 (11): 3100–5. PMID 15514282.
Beulens JW, Bots ML, Atsma F; et al. (2009). "High dietary menaquinone intake is associated with reduced coronary calcification". Atherosclerosis 203 (2): 489–93. PMID 18722618. doi:10.1016/j.atherosclerosis.2008.07.010.
Nimptsch K, Rohrmann S, Kaaks R, Linseisen J (2010). "Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg)". Am. J. Clin. Nutr. 91 (5): 1348–58. PMID 20335553. doi:10.3945/ajcn.2009.28691.
Ushiroyama, T; Ikeda A, Ueki M (2002). "Effect of continuous combined therapy with vitamin K2 and vitamin D3 on bone mineral density and coagulofibrinolysis function in postmenopausal women". Maturitas 41 (3): 211–221. PMID 11886767. doi:10.1016/S0378-5122(01)00275-4.
Asakura, H; Myou S, Ontachi Y, Mizutani T, Kato M, Saito M, Morishita E, Yamazaki M, Nakao S (2001). "Vitamin K administration to elderly patients with osteoporosis induces no hemostatic activation, even in those with suspected vitamin K deficiency". Osteoporosis International 12 (12): 996–1000. PMID 11846334. doi:10.1007/s001980170007.
Ronden, JE; Groenen-van Dooren MMCL, Hornstra G, Vermeer C (1997). "Modulation of arterial thrombosis tendency in rats by vitamin K and its side chains". Atherosclerosis 132 (1): 61–67. PMID 9247360. doi:10.1016/S0021-9150(97)00087-7.
Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E (2004). "The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy". Chest 126 (3 Suppl): 204S–233S. PMID 15383473. doi:10.1378/chest.126.3_suppl.204S. Arquivado dende o orixinal o 30 de decembro de 2008. Consultado o 01 de novembro de 2011. (summary Arquivado 11 de outubro de 2008 en Wayback Machine.)
Crowther MA, Douketis JD, Schnurr T; et al. (2002). "Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial" (PDF). Ann. Intern. Med. 137 (4): 251–4. PMID 12186515.
Elder SJ, Haytowitz DB, Howe J, Peterson JW, Booth SL (2006). "Vitamin k contents of meat, dairy, and fast food in the U.S. Diet". J. Agric. Food Chem. 54 (2): 463–7. PMID 16417305. doi:10.1021/jf052400h.
Tsukamoto Y, Ichise H, Kakuda H, Yamaguchi M (2000). "Intake of fermented soybean (natto) increases circulating vitamin K₂ (menaquinone-7) and gamma-carboxylated osteocalcin concentration in normal individuals". J. Bone Miner. Metab. 18 (4): 216–22. PMID 10874601. doi:10.1007/s007740070023.
Ikeda; Iki, M; Morita, A; Kajita, E; Kagamimori, S; Kagawa, Y; Yoneshima, H (2006). "Intake of fermented soybeans, natto, is associated with reduced bone loss in postmenopausal women: Japanese Population-Based Osteoporosis (JPOS) Study". The Journal of nutrition 136 (5): 1323–8. PMID 16614424.
Katsuyama; Ideguchi, S; Fukunaga, M; Saijoh, K; Sunami, S (2002). "Usual dietary intake of fermented soybeans (Natto) is associated with bone mineral density in premenopausal women". Journal of nutritional science and vitaminology 48 (3): 207–15. PMID 12350079. doi:10.3177/jnsv.48.207.
Sano; Fujita, H; Morita, I; Uematsu, H; Murota, S (1999). "Vitamin K2 (menatetrenone) induces iNOS in bovine vascular smooth muscle cells: no relationship between nitric oxide production and gamma-carboxylation". Journal of nutritional science and vitaminology 45 (6): 711–23. PMID 10737225. doi:10.3177/jnsv.45.711.
Oldenburg J, Bevans CG, Müller CR, Watzka M (2006). "Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle". Antioxid. Redox Signal. 8 (3–4): 347–53. PMID 16677080. doi:10.1089/ars.2006.8.347.
Suttie JW (1985). "Vitamin K-dependent carboxylase". Annu. Rev. Biochem. 54: 459–77. PMID 3896125. doi:10.1146/annurev.bi.54.070185.002331.
Presnell SR, Stafford DW (2002). "The vitamin K-dependent carboxylase". Thromb. Haemost. 87 (6): 937–46. PMID 12083499.
Stafford DW (2005). "The vitamin K cycle". J. Thromb. Haemost. 3 (8): 1873–8. PMID 16102054. doi:10.1111/j.1538-7836.2005.01419.x.
Whitlon DS, Sadowski JA, Suttie JW (1978). "Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition". Biochemistry 17 (8): 1371–7. PMID 646989. doi:10.1021/bi00601a003.
Terlau H, Olivera BM (2004). "Conus venoms: a rich source of novel ion channel-targeted peptides". Physiol. Rev. 84 (1): 41–68. PMID 14715910. doi:10.1152/physrev.00020.2003.
Buczek O, Bulaj G, Olivera BM (2005). "Conotoxins and the posttranslational modification of secreted gene products". Cell. Mol. Life Sci. 62 (24): 3067–79. PMID 16314929. doi:10.1007/s00018-005-5283-0.
Bentley R, Meganathan R (1982). "Biosynthesis of vitamin K (menaquinone) in bacteria". Microbiol. Rev. 46 (3): 241–80. PMC 281544. PMID 6127606.
Haddock BA, Jones CW (1977). "Bacterial respiration". Bacteriol Rev 41 (1): 47–99. PMC 413996. PMID 140652.
Gerald JA, Katie JW, Asiri R W; et al. (2009). "Vitamin K promotes mineralization, osteoblast‐to‐osteocyte transition, and an anticatabolic phenotype by γ‐carboxylation‐dependent and independent mechanisms". Am J Physiol Cell Physiol 297 (6): C1358–C1367. PMID 19675304. doi:10.1152/ajpcell.00216.2009.
Lian J, Stewart C, Puchacz E, Mackowiak S, Shalhoub V, Collart D, Zambetti G & Stein G (1989). "Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression". Proc Natl Acad Sci 86 (4): 1143–1147. PMC 286642. PMID 2784002. doi:10.1073/pnas.86.4.1143.
Booth SL, Tucker K, Chen H; et al. (2000). "Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women". Am J Clin Nutr 71 (5): 1201–1208. PMID 10799384.
Cheung, AM; Weber, P; Willett, WC; Rockett, H; Booth, SL; Colditz, GA; Hu, H; Vieth, R; Thompson, L (2008). Torgerson, David, ed. "Vitamin K Supplementation in Postmenopausal Women with Osteopenia (ECKO Trial): A Randomized Controlled Trial". PLoS Med. 5 (10): e196. PMC 2566998. PMID 18922041. doi:10.1371/journal.pmed.0050196.
Feskanich, Diane; Weber, P; Willett, W; Rockett, H; Booth, S; Colditz, G (1999). "Vitamin K intake and hip fractures in women: a prospective study". American Journal of Clinical Nutrition 69 (1): 74–9. PMID 9925126.
Yamaguchi M (2006). "Regulatory mechanism of food factors in bone metabolism and prevention of osteoporosis". Yakugaku Zasshi 126 (11): 1117–37. PMID 17077614.
Tsukamoto Y (2004). "Studies on action of menaquinone-7 in regulation of bone metabolism and its preventive role of osteoporosis". BioFactors 22 (1-4): 5–19. PMID 15630245. doi:10.1002/biof.5520220102.
Sato, Y; Kanoko T, Satoh K, Iwamoto J (2005). "Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease". Bone 36 (1): 61–8. PMID 15664003. doi:10.1016/j.bone.2004.09.018.
Iwamoto, I; Kosha S, Noguchi S-i (1999). "A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy". Maturitas 31 (2): 161–164. PMID 10227010. doi:10.1016/S0378-5122(98)00114-5.
Inoue, T; Sugiyama T, Matsubara T, Kawai S, Furukawa S (2001). "Inverse correlation between the changes of lumbar bone mineral density and serum undercarboxylated osteocalcin after vitamin K2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol". Endocrine Journal 48 (1): 11–18. PMID 11403096. doi:10.1507/endocrj.48.11.
Sasaki, N, Kusano E, Takahashi H, Ando Y, Yano K, Tsuda E, Asano Y; Kusano E, Takahashi H, Ando Y, Yano K, Tsuda E, Asano Y (2005). "Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG)". Journal of bone and mineral metabolism 23 (1): 41–47. PMID 15616893. doi:10.1007/s00774-004-0539-6.
Yonemura, K; Fukasawa H, Fujigaki Y, Hishida A. (2004). "Protective effect of vitamins K2 and D3 on prednisolone-induced loss of bone mineral density in the lumbar spine". American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation 43 (1): 53–60. PMID 14712427.
Yonemura, K; Kimura M, Miyaji T, Hishida A (2000). "Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis". Calcified Tissue International 66 (2): 123–128. PMID 10652960. doi:10.1007/PL00005832.
Iketani, T; Kiriike N, B. Stein M (2003). "Effect of menatetrenone (vitamin K2) treatment on bone loss in patients with anorexia nervosa". Psychiatry Research 117 (3): 259–269. PMID 12686368. doi:10.1016/S0165-1781(03)00024-6.
Shiomi, S; Nishiguchi S, Kubo S (2002). "Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver". The American Journal of Gastroenterology 97 (4): 978–981. PMID 12003435. doi:10.1111/j.1572-0241.2002.05618.x.
Cockayne, S; Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ (2006). "Vitamin K and the Prevention of Fractures: Systematic Review and Meta-analysis of Randomized Controlled Trials". Archives of Internal Medicine 166 (12): 1256–1261. PMID 16801507. doi:10.1001/archinte.166.12.1256.
Iwamoto, J; Takeda T, Ichimura S (2000). "Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis". Journal of Orthopaedic Science 5 (6): 546–551. PMID 11180916. doi:10.1007/s007760070003.
Purwosunu, Y; Muharram, Rachman IA, Reksoprodjo S, Sekizawa A (2006). "Vitamin K2 treatment for postmenopausal osteoporosis in Indonesia". The journal of obstetrics and gynaecology research 32 (2): 230–234. PMID 16594930. doi:10.1111/j.1447-0756.2006.00386.x.
Shiraki, M; Shiraki Y, Aoki C, Miura M (2000). "Vitamin K2 (Menatetrenone) Effectively Prevents Fractures and Sustains Lumbar Bone Mineral Density in Osteoporosis". Journal of Bone and Mineral Research 15 (3): 515–522. PMID 10750566. doi:10.1359/jbmr.2000.15.3.515.
Sato, Y; Honda Y, Kuno H, Oizumi K (1998). "Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients". Bone 23 (3): 291–296. PMID 9737352. doi:10.1016/S8756-3282(98)00108-2.
Sato, Y; Kanoko T, Satoh K, Iwamoto J (2005). "Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease". Bone 36 (1): 61–68. PMID 15664003. doi:10.1016/j.bone.2004.09.018.
Sato, Y; Honda Y, Kaji M (2002). "Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency". Bone 31 (1): 114–118. PMID 12110423. doi:10.1016/S8756-3282(02)00783-4.
Nishiguchi, S; Shimoi S, Kurooka H (2001). "Randomized pilot trial of vitamin K2 for bone loss in patients with primary biliary cirrhosis". Journal of Hepatology 35 (4): 543–545. PMID 11682046. doi:10.1016/S0168-8278(01)00133-7.
Somekawa, Y; Chigughi M, Harada M, Ishibashi T (1999). "Use of vitamin K2 (menatetrenone) and 1,25-dihydroxyvitamin D3 in the prevention of bone loss induced by leuprolide". The Journal of clinical endocrinology and metabolism 84 (8): 2700–2704. PMID 10443663. doi:10.1210/jc.84.8.2700.
Allison (2001). "The possible role of vitamin K deficiency in the pathogenesis of Alzheimer's disease and in augmenting brain damage associated with cardiovascular disease". Medical hypotheses 57 (2): 151–5. PMID 11461163. doi:10.1054/mehy.2001.1307.
Saxena SP, Israels ED, Israels LG (2001). "Novel vitamin K-dependent pathways regulating cell survival". Apoptosis 6 (1–2): 57–68. PMID 11321042. doi:10.1023/A:1009624111275.
Nimptsch K, Rohrmann S, Linseisen J (2008). "Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition. (EPIC-Heidelberg)". Am. J. Clin. Nutr. 87 (4): 985–92. PMID 18400723.
Spronk, HMH; Soute BAM, Schurgers LJ, Thijssen HHW, De Mey JGR, Vermeer C (2003). "Tissue-Specific Utilization of Menaquinone-4 Results in the Prevention of Arterial Calcification in Warfarin-Treated Rats". Journal of vascular research 40 (6): 531–537. PMID 14654717. doi:10.1159/000075344.
Stenflo J, Fernlund P, Egan W, Roepstorff P (1974). "Vitamin K Dependent Modifications of Glutamic Acid Residues in Prothrombin". Proc. Natl. Acad. Sci. U.S.A. 71 (7): 2730–3. PMC 388542. PMID 4528109. doi:10.1073/pnas.71.7.2730.
Nelsestuen GL, Zytkovicz TH, Howard JB (1974). "The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin". J. Biol. Chem. 249 (19): 6347–50. PMID 4214105. Arquivado dende o orixinal o 19 de setembro de 2019. Consultado o 01 de novembro de 2011.
Magnusson S, Sottrup-Jensen L, Petersen TE, Morris HR, Dell A (1974). "Primary structure of the vitamin K-dependent part of prothrombin". FEBS Lett. 44 (2): 189–93. PMID 4472513. doi:10.1016/0014-5793(74)80723-4.

nlm.nih.gov

McGee, W (2007-02-01). "Vitamin K". MedlinePlus. Consultado o 02-11-2011.
"Vitamin K". Consultado o 2009-05-26.

nobelprize.org

Dam, Henrik (December 12, 1946). The discovery of vitamin K, its biological functions and therapeutical application. Arquivado 11 de decembro de 2011 en Wayback Machine. Nobel Prize lecture

nutraingredients.com

"Vitamin K Found to Protect Against Liver Cancer"

nutrition.org

jn.nutrition.org

Geleijnse JM, Vermeer C, Grobbee DE; et al. (2004). "Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study". J. Nutr. 134 (11): 3100–5. PMID 15514282.

nutritiondata.com

Nutrition Facts and Information for Parsley, raw
"Nutrition facts, calories in food, labels, nutritional information and analysis – NutritionData.com". Arquivado dende o orixinal o 06 de xullo de 2010. Consultado o 01 de novembro de 2011.

oregonstate.edu

lpi.oregonstate.edu

Higdon (February 2008). "Vitamin K". Linus Pauling Institute, Oregon State University. Consultado o 01-11-2011.

oup.com

academic.oup.com

Geleijnse, Johanna M.; Vermeer, Cees; Grobbee, Diederick E.; Schurgers, Leon J.; Knapen, Marjo H. J.; van der Meer, Irene M.; Hofman, Albert; Witteman, Jacqueline C. M. (2004-11-01). "Dietary Intake of Menaquinone Is Associated with a Reduced Risk of Coronary Heart Disease: The Rotterdam Study". The Journal of Nutrition (en inglés) 134 (11): 3100–3105. ISSN 0022-3166. doi:10.1093/jn/134.11.3100.

schattauer.de

Mann KG (1999). "Biochemistry and physiology of blood coagulation". Thromb. Haemost. 82 (2): 165–74. PMID 10605701. Arquivado dende o orixinal o 02 de xaneiro de 2009. Consultado o 01 de novembro de 2011.

springer.com

link.springer.com

Tsukamoto Y, Ichise H, Kakuda H, Yamaguchi M (2000). "Intake of fermented soybean (natto) increases circulating vitamin K₂ (menaquinone-7) and gamma-carboxylated osteocalcin concentration in normal individuals". J. Bone Miner. Metab. 18 (4): 216–22. PMID 10874601. doi:10.1007/s007740070023.

web.archive.org

Furie B, Bouchard BA, Furie BC (15 March 1999). "Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid". Blood 93 (6): 1798–808. PMID 10068650. Arquivado dende o orixinal o 12 de febreiro de 2009. Consultado o 01 de novembro de 2011.
Mann KG (1999). "Biochemistry and physiology of blood coagulation". Thromb. Haemost. 82 (2): 165–74. PMID 10605701. Arquivado dende o orixinal o 02 de xaneiro de 2009. Consultado o 01 de novembro de 2011.
Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E (2004). "The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy". Chest 126 (3 Suppl): 204S–233S. PMID 15383473. doi:10.1378/chest.126.3_suppl.204S. Arquivado dende o orixinal o 30 de decembro de 2008. Consultado o 01 de novembro de 2011. (summary Arquivado 11 de outubro de 2008 en Wayback Machine.)
"Nutrition facts, calories in food, labels, nutritional information and analysis – NutritionData.com". Arquivado dende o orixinal o 06 de xullo de 2010. Consultado o 01 de novembro de 2011.
"NutritionData.com". Arquivado dende o orixinal o 17 de novembro de 2011. Consultado o 01 de novembro de 2011.
Dam, Henrik (December 12, 1946). The discovery of vitamin K, its biological functions and therapeutical application. Arquivado 11 de decembro de 2011 en Wayback Machine. Nobel Prize lecture
Nelsestuen GL, Zytkovicz TH, Howard JB (1974). "The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin". J. Biol. Chem. 249 (19): 6347–50. PMID 4214105. Arquivado dende o orixinal o 19 de setembro de 2019. Consultado o 01 de novembro de 2011.

westonaprice.org

"On the Trail of the Elusive X-Factor: Vitamin K2 Revealed".

wiley.com

onlinelibrary.wiley.com

Tsukamoto Y (2004). "Studies on action of menaquinone-7 in regulation of bone metabolism and its preventive role of osteoporosis". BioFactors 22 (1-4): 5–19. PMID 15630245. doi:10.1002/biof.5520220102.

womentowomen.com

Dr. Susan E. Brown, PhD. "Key vitamins for bone health — vitamins K1 and K2". womentowomen.com. Consultado o 11 August 2010.

worldcat.org

Geleijnse, Johanna M.; Vermeer, Cees; Grobbee, Diederick E.; Schurgers, Leon J.; Knapen, Marjo H. J.; van der Meer, Irene M.; Hofman, Albert; Witteman, Jacqueline C. M. (2004-11-01). "Dietary Intake of Menaquinone Is Associated with a Reduced Risk of Coronary Heart Disease: The Rotterdam Study". The Journal of Nutrition (en inglés) 134 (11): 3100–3105. ISSN 0022-3166. doi:10.1093/jn/134.11.3100.